LAG3 and cancer: Liver sinusoidal endothelial cell lectin (LSECtin) and Galectin-3 have been speculated to be additional ligands for LAG3 and have been found to be expressed on cancer cells to inhibit IFNγ secretion by CD8+ T cells (171).